Pharming Group (PHAR)
9.30
-0.25
(-2.62%)
USD |
NASDAQ |
May 17, 16:00
Pharming Group Gross Profit (TTM): 228.84M for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 228.84M |
December 31, 2023 | 220.10M |
September 30, 2023 | 194.35M |
June 30, 2023 | 187.84M |
March 31, 2023 | 184.79M |
December 31, 2022 | 188.06M |
September 30, 2022 | 186.84M |
June 30, 2022 | 181.84M |
March 31, 2022 | 180.75M |
December 31, 2021 | 177.73M |
September 30, 2021 | 178.33M |
June 30, 2021 | 183.83M |
March 31, 2021 | 178.93M |
December 31, 2020 | 188.64M |
September 30, 2020 | 189.21M |
June 30, 2020 | 177.86M |
March 31, 2020 | 180.41M |
December 31, 2019 | 165.46M |
September 30, 2019 | 150.57M |
June 30, 2019 | 147.57M |
March 31, 2019 | 132.52M |
December 31, 2018 | 129.20M |
September 30, 2018 | 131.07M |
June 30, 2018 | 119.50M |
March 31, 2018 | 108.04M |
Date | Value |
---|---|
December 31, 2017 | 92.59M |
September 30, 2017 | 62.95M |
June 30, 2017 | 39.00M |
March 31, 2017 | 24.71M |
December 31, 2016 | 11.77M |
September 30, 2016 | 7.368M |
June 30, 2016 | 6.993M |
March 31, 2016 | 7.512M |
December 31, 2015 | 6.590M |
September 30, 2015 | 25.44M |
June 30, 2015 | 23.82M |
March 31, 2015 | 22.16M |
December 31, 2014 | 21.60M |
September 30, 2014 | 1.926M |
June 30, 2014 | 2.542M |
March 31, 2014 | 7.573M |
December 31, 2013 | 7.915M |
September 30, 2013 | 17.11M |
June 30, 2013 | 16.38M |
March 31, 2013 | 8.367M |
December 31, 2012 | 8.393M |
September 30, 2012 | -1.731M |
June 30, 2012 | -2.604M |
March 31, 2012 | -0.7725M |
December 31, 2011 | -0.6882M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
147.57M
Minimum
Jun 2019
228.84M
Maximum
Mar 2024
183.60M
Average
182.84M
Median
Gross Profit (TTM) Benchmarks
uniQure NV | -1.416M |
ProQR Therapeutics NV | -- |
Merus NV | -- |
argenx SE | 1.265B |
Pharvaris NV | -- |